Fig. 5From: Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99Kaplan-Meier curves depicting the OS of patients in Arm A with no change (green), increased (red), and decreased (black) ECDHER2 values at first assessment compared to baseline valuesBack to article page